DIY Wedding Favors For the Pink Ribbon Cause

Brides can remember their loved ones by given Pink Coloured DIY Wedding Favors in their loved ones memory, to their wedding guests after the speeches and wedding meal has finished.

In order to raise awareness of breast cancer several designers have come up with ideas for brides to say a thank you to their loved ones who are unable to attend their wedding. This will hopefully raise awareness for breast cancer in the form of the pink ribbon idea. Some companies offer a small percentage of the sale price of the pink goods to go to breast cancer charities to help them either in research or publishing leaflets to help prevent breast cancer.

Tranquility Soy Candles offers a line of Pink Ribbon Soy Candles and can supply soy candle wedding favors .  Click on this link Pink Ribbon Soy Candles to learn more.

Brides can perhaps order some wine as a wedding favor. They can decorate the wine bottle with some pink polka dot ribbon tied around the neck of the wine bottle. Or you can perhaps order some pink wine and attach some pink ribbons around the bottle as a wedding favour gesture.
The wine can be used for drinking during your meal or if you have ordered a miniature pink bottle of wine as a wedding favour , I am sure your guests will appreciate your goodwill sentiment.

You can also use the favor boxes as a wedding favor idea. Choose a pink square box and then tie a gold ribbon or silver ribbon bow and then attach to the outside of the box. Fill with pink candy and there you have a pink ribbon candy favor wedding box.

Brides can also order pink photograph frames as a wedding favour idea. This will also look fabulous on your table as pink ribbon decorations.

Perhaps brides would like to give a more everlasting wedding favor gift in the form of a seeds which can be planted from a packet in the shape of a ribbon which is pink in color.

Sometimes in local stores in certain times of the year you can purchase pink accessories on behalf of breast cancer. The accessories can be purchased a year in advance if you are sure of your date.
Some of the items purchased can also be used a table top decorations.

Kath Anderson is a writer for DIY Wedding Favors at http://www.mydiyweddingfavors.com.

The original of this article can be found on My DIY Wedding Favors
Copyright 2009 – Kath Anderson. All Rights Reserved Worldwide. Reprint Rights: You may reprint this article as long as you leave all of the links active, do not edit the article in any way, give author name credit and follow all of the EzineArticles terms of service for Publishers.

Pink Ribbon and an Awareness of Breast Cancer

October is the Breast Cancer Awareness Month. The major breast cancer and cancer charities all over the UK will champion the cause, employing the pink ribbon now as a global symbol of its awareness. Pink Ribbon Day is always on the fourth Monday of October. It marks the culmination of breast cancer activities during the month of October. The Day raises funds for research into the prevention, diagnosis and treatment of it.

It was approximately the early 90s that ribbons grow to be a successful means for encouraging awareness in relation to cancer. It begun with pink ribbons for breast cancer and at the present there are different colors representing reinforcement to battle all kind of cancer. Lavender ribbons assign common cancer awareness. Teal ribbons give your approval to support for ovarian cancer, cervical cancer and uterine cancer as well.

However, mainly well-liked amongst all cancer ribbons is the pink ribbon that has turn into a worldwide symbol of optimism for breast cancer. Grounds are understandable. Breast cancer is predicted to have an effect on 2,600,000 plus women in the United States only. In accordance with the United States National Cancer Institute, it is the most widespread type of cancer (apart from skin cancer) amongst women in the United States.

The pink ribbons demonstrate everybody that you concern concerning and are attracted in discovering a therapy for breast cancer. Whether you just dress in a pink ribbon or you are more communally lively in the concern depends upon your individual experiences with breast cancer.

Nowadays, famous people in the movie industry as well as corporations are displaying their encouragement of numerous dissimilar causes. One of the more well-liked one, principally for women, is the breast cancer ribbon. You will witness well-known people dressing in the pink ribbons on their fancy stylist gowns as they walk down the Red Carpet at the Oscar’s or Emmy’s. They are not embarrassed to demonstrate their admirers that they mind regarding a particular issue of awareness to the public.

You could assist raise your communities breast cancer awareness and reinforcement its study at the same time by conceitedly wearing your ribbon. All and everybody of us could make a different in the struggle in opposition to breast cancer. In addition to, all you require to act is buy a little pink breast cancer awareness ribbon. Just choose one and prove your support!

If you want to get some excellent resources on Breast Cancer, please visit my site on All about Breast Cancer or Breast Cancer and Pink Ribbon

Unraveling the Pink Ribbon – The Most Aggressive Form of Breast Cancer

It doesn’t come wrapped in a little pink ribbon. It doesn’t come with a cute “breast cancer awareness” pen, stuffed animal, umbrella or any other marketable items. It comes with a grizzly 2-inch open sore beneath a purplish-red breast swollen to twice its normal size. This is the “silent killer” that, according to information from the and National Cancer Institute, accounts for one to five percent of all U.S. breast cancer cases and kills about 60 percent of patients within five years. Victims of Inflammatory Breast Cancer (IBC) are far from having a “cute” experience.

The Past

For Linda Gamble, a retired high school teacher from Pensacola, Fla., IBC was one of the most terrifying experiences she ever witnessed when her sister, homemaker Mary Ann Garber, was diagnosed with the disease on Oct. 7, 2002. One morning before Gamble went to work, Garber approached her, worried that the under wire in her new bras might have caused an infection. Her right breast was swollen to the size of a football, with large red open sores. “[When I saw it] what I felt was terror,” Gamble said. “To me, that looked like what cancer would look like.” Immediately, Gamble took her sister to a local practitioner. “He stepped back in shock,” Gamble said. “Then he called all his nurses in to see it.” Garber was diagnosed as stage IIIB, meaning the cancer had not yet spread to other organs. IBC has a faster doubling time than other types of cancers, spreading throughout the breast in sheets or nests, which are undetectable in mammograms, according to the Inflammatory Breast Cancer Research Foundation.

The nests clog breast tissue vessels, causing the breast to heat and swell. Garber was soon given news that she had approximately six more months to live. Immediately starting the rigorous plan of chemotherapy, a mastectomy in January 2003 and radiation therapy, she maintained optimistic, despite the grim outlook. “She didn’t believe it,” Gamble said. “She kept saying ‘I’ve never been sick a day in my life, so how could this be happening to me?’” Before her first mastectomy, Garber was treated with Adriamycin-Cytoxan, a form of chemotherapy that shrank her tumor by half its original size. Shortly after her surgery, the open sores reappeared over Garber’s mastectomy scars and spread to her left breast. When the open sores kept reappearing, Garber was diagnosed as stage IV, meaning the cancer had moved to other organs. Misdiagnosis is very common when it comes to IBC, according to information from IBCRF. Many victims are misdiagnosed with mastitis, a breast infection, and are prescribed antibiotics. “It was spreading so fast, it was unbelievable,” Gamble said. “Time is of the essence with IBC.” Also of the essence is ability to correctly define the cancer, according to IBCRF. Clinical IBC diagnosis is based on abnormal redness of the skin, skin swelling and an orange skin color. While such characteristics can be helpful in identifying the cancer, scientists are still researching what causes it, including having other types of breast cancer throughout family history, according to the NCI. Between the clinical and gene-related characteristics, IBC is very broadly defined.

The Present

IBC diagnosis was a gradually defined process for Charlotte Bryant, 59, an IBC survivor from Greenville, N.C. and contributor to the IBCRF web site. Bryant began noticing infrequent itching and discomfort around her left nipple from February to April 13, 2001. Two weeks later while she was out of town on business, the tissue across her breast became hard, feverish and painfully swollen. “[The symptoms] seemed to appear overnight,” Bryant said on the IBCRF web site. “I saw my doctor and he gave me [an antibiotic].” Time lost during misdiagnosis is one reason for the 40 percent survival rate, according to the IBCF. Other causes are a physician’s lack of experience treating IBC, and the cancer’s poor response to standard chemotherapy. After feeling a hard 8.8cm mass in her breast, Bryant returned for a mammogram and ultrasound in May.

The radiologist still did not know what it was, and sent Bryant back to her doctor. During a surgical appointment, Bryant was first told she had a 50/50 chance of having breast cancer. The next day, Bryant’s husband searched the Internet for his wife’s symptoms and came across the term “inflammatory breast cancer.” Those three words were Bryant’s diagnosis on May 14, 2001. “On Wednesday afternoon, a dear friend brought two of her powerful Christian friends to my office for healing prayer,” Bryant said. “I left that room with a big smile, saying, ‘I am going to be just fine!’” Bryant began the Adriamycin-Cytoxan chemotherapy on May 17, even heading back to work the following Monday with a positive outlook. “By the next chemo one week later, I was wearing my new wig,” Bryant said. “I felt that if I saw myself with no hair, I would look sick and I refused to be sick.” Her optimism was interrupted three weeks later, when her radiologist found two metastases on her vertebrae. Bryant was now stage IV. When she met with a Duke University Medical Center oncologist two weeks after her diagnosis, he gave the impression that he did not expect Bryant to live much longer. She refused to believe him. “He was not very encouraging and explained that this was a serious breast cancer,” Bryant said. “I told [my husband] and myself then that I was going to prove them wrong.” Bryant had surgery on Aug. 8, 2001 and completed all her radiation treatments on Jan. 28, 2002. She receives scans every six months and has remained stable so far.

Garber’s strength ended on July 31, 2003 when she lost her battle at 7:58 p.m. in West Florida Hospital, approximately four months before her 50th birthday. Average victims are diagnosed at age 56, according to IBCF. Other breast cancer victims are diagnosed, on average, around age 62. “She was fine and talkative and then one day she asked the nurse to take out her IV because it ‘hurt,’” Gamble said. “I kept saying, ‘but you need your IV; you’re not eating,’ and she would say, ‘I’ll get it put back in as soon as I start feeling better.’” Shortly after Garber had her IV taken out, she fell asleep and Gamble could not awaken her. Bryant has spent her recovery reaching out to such patients through the American Cancer Society Reach to Recovery program, where she volunteers. “I have met several IBC patients, and do everything I can to encourage them,” Bryant said. “I like to give other patients hope.” Gamble found hope on Oct. 25, 2006 while attending the opening of the new University of Texas M.D. Anderson Research Program for Inflammatory Breast Cancer, the first center in the world dedicated solely to the rare disease. Co-director Dr. Massimo Cristofanilli, associate professor in the Department of Breast Medical Oncology, said in the opening news release that the clinic’s primary goal is to “finally understand why this disease is different, why it is so resistant to treatment, and ultimately to develop therapies that improve the well-being of women with this very rare form of breast cancer.” “[The opening] was wonderful,” Gamble said. “I’ve been getting mammograms for 16 years and no one has ever mentioned these symptoms to me.”

The Future I

It was about three days before her menstrual cycle in September when Lisa Paris’ husband pointed out two symptoms on her right breast. Her nipple was sunken in and her breast was turning red and dimpling. “I told him I would give it a couple of days to see if it went back to normal after I started,” said Paris, 44, a manufacturer from Fairfax, Mo. “The week of my period I tend to get very tender breast.” But the symptoms remained two days later, and Paris made an appointment with her family doctor. Only a few minutes after looking at it, her doctor told Paris she had cancer. To make the diagnosis official, he scheduled a mammogram appointment on Oct. 2 and a lymph node and skin biopsy on Oct. 5. “They used an ultrasound first to see if they could find a place to biopsy since there really was no lump of any kind,” Paris said. “It was more of a mass.” Paris had fast-growing stage III Inflammatory Breast Cancer. She started her first six-hour chemotherapy treatment on Oct. 16. “My feelings were all over the place-scared, angry, pissed, numb,” Paris said. “The one thing I know is this thing will not beat me.” Most of Paris’ family was shocked when they heard her diagnosis, since there is no history of cancer in her family. When her friends and co-workers heard the news, they raised about $ 3,000 for her medical bills.

Half of Paris’ chemotherapy was completed on Nov. 20. She is planning to have surgery in January, depending on the diagnosis of a spot recently found on her lung. “If the spot is still there, they will biopsy it,” Paris said. “If it’s not scar tissue and turns out to be cancer, then probably more chemo before surgery.” Working around chemotherapy appointments has been the only change in Paris’ life since the diagnosis. She still spends time with her family and friends, sees her grandchildren and still has card night with her friends every Saturday. “I’m not putting my life on hold for this thing,” Paris said. “If, by chance, it does go the wrong way, I don’t want to have any regrets.” Paris recently tested negative for the BRACA1/BRACA2 gene, which links to hereditary breast and ovarian cancer, according to the NCI. She hopes her results can put her family at ease.

A new gene was discovered in June, when scientists from The Cancer Institute at New York University Langone Medical Center identified eIF4G1 as overexposed in the majority of IBC cases, allowing the cancerous cells to more rapidly form the clusters responsible for spreading, according to IBCRF. The breakthrough could lead to new approaches, therapies and classes of drugs to target and treat IBC. “I hope this new test can shed some light on the whole IBC thing,” Paris said. “If not to help me, but to help any one in the future who happens to be as unlucky as the rest of us who already have this stupid cancer.”

Although it is known by many as “silent,” IBC is not invisible. But it is certainly not “cute.”

Breast Cancer Surgery: Lumpectomy, Mastectomy

Breast Cancer Surgery: Lumpectomy, Mastectomy

www.nucleusinc.com This 3D patient education medical animation depicts various surgical procedures to remove breast cancer lumps and tumors. The surgeries include lumpectomy, simple mastectomy, modified radical mastectomy, and radical mastectomy surgery.

UK Recommends Against Buying Breast Cancer Drug

UK Recommends Against Buying Breast Cancer Drug

Breast Cancer Pink RibbonLONDON — Britain’s health watchdog on Thursday recommended against buying a breast cancer drug for patients with advanced disease.

In a statement, the National Institute for Health and Clinical Excellence said that lapatinib, sold as Tyverb by GlaxoSmithKline PLC, is not cost-effective. The drug costs about 1,600 pounds ($2,300) per treatment course in Britain. Glaxo said the decision would mean about 2,000 patients in the U.K. will no longer get the drug.

Tyverb is given to women with advanced breast cancer in combination with another drug, after they have failed to improve with standard medicines like Herceptin. There are no other licensed treatments available to treat these women. The drug is widely available in countries including the U.S., Iceland, Czech Republic and elsewhere.

Glaxo called the decision “deeply disappointing.”

Publish Date: 06/10/2010 11:22

http://www.huffingtonpost.com/2010/06/10/uk-recommends-against-buy_n_607392.html

Adherence With Oral Meds-An Issue In Breast Cancer

Breast Cancer DrugsAdherence With Oral Meds-An Issue In Breast Cancer “Drugs don’t work in patients who don’t take them.”

In the battle against breast cancer, patients are increasingly prescribed oral medications, such as hormonal therapy, to limit the risk of disease recurrence. Research has indicated that patients should stay on these drugs for five years to gain maximum benefits.

But recently, the healthcare community has started to ask a question once limited to managing common colds, not cancer: Do breast cancer patients take their medications as prescribed?

According to the American Cancer Society, more than 200,000 new cases of breast cancer are diagnosed every year in the U.S. Of those, approximately 100,000 have cancer types that are likely to respond to hormonal therapy.

Taking the therapy as prescribed for the full five years can reduce their risk of recurrence.

Easier Said than Done

Based on findings from a recent symposium on medication adherence among breast cancer patients, candidates for hormonal therapy-some 500,000 women in the U.S.-may not be reaping the full benefits of their drug regimens.

According to some research studies, non-compliance rates have reached as high as 40 percent.

The Symposium, called the Compliance Strategic Initiative (CSI), addressed issues that lead to medication non-compliance among breast cancer patients, and it identified possible solutions to these issues. Representatives from leading patient advocacy organizations and professional healthcare associations, as well as oncology experts and survivors from across the nation, gathered to share their perspectives.

The CSI was led by a Steering Committee which included representatives from the American Cancer Society, CancerCare, the National Surgical Adjuvant Breast and Bowel Project (NSABP), and Y-ME National Breast Cancer Organization.

“Through research, we know that five years of adjuvant hormonal therapy in women with estrogen receptor-positive breast cancer prolongs survival and reduces recurrence,” said D. Lawrence Wickerham, MD, associate chairman of the National Surgical Adjuvant Breast and Bowel Project. “And yet, studies also show that not all patients stay on hormonal therapy as prescribed.

It is important that healthcare providers understand why women make that decision, so we can address the issue with the information, resources and support needed to help them through this part of their treatment.”

Based on results of the meeting, participants gained a better understanding of the factors that contributed to non-compliance. Among those factors: patients often do not feel empowered to talk with their doctors about tough issues, such as side effects; doctors and other healthcare professionals aren’t equipped with resources to assist patients in coping with or eliminating side effects; and after their acute phase of treatment, women may often feel they are left to manage therapy on their own.

Physicians are under increasing pressures of time and performance and may not always have the skill set to listen well to their patients, or, simply not realize their patients may not be taking their medication. These factors combine to create communication gaps through which compliance issues can fall.

In conclusion, breast oncology advocates and experts who attended the symposium agreed that patient support mechanisms can and must be improved. Healthcare providers and patients each play pivotal roles. Through education and communication, they can begin to take the steps that will help some breast cancer patients reduce their risk of recurrence.

Two in five breast cancer patients don’t take their medication properly.

A 10-Year Drive To Put The Brakes On Breast Cancer

Breast Cancer Self Diagnosis

Breast Cancer Self Diagnosis

Breast cancer is a highly treatable disease that now has a survival rate of 85 percent. Yet more than 212,000 women are still diagnosed with the condition each year.

Since early diagnosis is an important key to successful treatment, doctors say it’s important that all women over the age of 18 do a Breast Self-Exam (BSE) every month, two or three days after their menstrual cycle. In addition, women between 20 and 39 should have a clinical breast exam at least every three years and women 40 and older should have a mammogram every year.

For the past 10 years, BMW of North America has worked with The Susan G. Komen Breast Cancer Foundation-the largest fund-raiser for breast cancer research in America-to help spread the message of early detection and to help ensure that breast cancer research continues. The groups’ Ultimate Drive program has raised millions to help fund the efforts.

The initiative, fully underwritten by BMW, consists of two fleets of specifically badged BMWs making a cross-country trek, stopping in communities along the way to hold daylong events. People will be invited to test-drive the cars-at no cost to the participants-to raise money for breast cancer research, education and screening treatment programs.

The car company donates $1 directly to the Komen Foundation for each mile driven, along with whatever other proceeds are received from the program. Upon completion of every drive, each participant adds his or her own name to the Signature Vehicle-this year, a BMW 3-Series.

This year’s goal is to raise over $1 million, bringing the program’s 10-year total up to over $10 million. To help celebrate the initiative’s 10th anniversary, the 240-stop cross-country trek has been expanded to include Alaska.

People can test-drive the cars to help fight breast cancer. They can also:

; Regularly conduct BSEs, have clinical exams and mammograms

; Stop smoking and stressing

; Get more exercise

; Cut or reduce their alcohol consumption

; Watch their diet. Try to eat plenty of olive oil, fruits, vegetables, grains, fresh fish and poultry.

Why A Pink Ribbon?

Breast Cancer Pink Ribbon

Breast Cancer Pink Ribbon

Why a Pink Ribbon for breast cancer awareness?

“Pink is the quintessential female color,” says Margaret Welch, director of the Color Association of the United States. “The profile on pink is playful, life-affirming. We have studies as to its calming effect, its quieting effect, its lessening of stress. [Pastel pink] is a shade known to be health-giving; that’s why we have expressions like ‘in the pink.’ You can’t say a bad thing about it.” Pink is, in other words, everything cancer notably is not.

One in ten women is diagnosed with breast cancer each year in the United States of America. It is the second largest killer after lung cancer and can affect both male and female. However, woman are one hundred time more likely to suffer from the disease than men.

The disease usually starts in the lining of the milk ducts and frequently manifests itself as a palpable lump either in the breast itself or in the arm pit, nipple inversion, bleeding nipple and much more. There are many different types of breast cancer and the survival rate depends on many factors. The most common treatments includes chemo-therapy, hormone-therapy, radiation-therapy and surgery. However, satisfying results have been achieved with various alternative therapies.

The battle has been raging against the disease for many years with many campaigns designed to raise funds for research, promoting awareness and funding treatment. The original idea began in 1991 with the Susan Komen Foundation, where pink ribbons were handed out to those participating in a fund raising event.

Then some time later, a cancer sufferer named Caroline Hayley produced and sold a card which contained a ‘peach’ coloured ribbon. The purpose of the card and the ribbon was to bring to the attention of the public and government legislators, the chronic lack of investment by the National Cancer Institute, who despite having a annual budget of almost two Billion USD, spent only 5%, which equated to a mere fraction of what they had available on cancer preventing.

The idea was well publicised and captured the public imagination, attracting a considerable amount of the attention from individuals like Evelyn Lauder of the Estee Lauder cosmetics giant and Alexander Penney editor of Women’s Health Magazine. They assisted with the distribution in stores and retail outlets across New York City, which eventually spread throughout the USA. With this success they approached Caroline Hayley to offer her their help, however she felt that the project would become too commercialised and so she declined their offer.

Not to be put off by her rejection Penney and Lauder sought legal advice and eventually came up with the ‘pink ribbon’ idea. Since then the pink ribbon has become an international symbol of breast cancer awareness and a symbol of solidarity on the part of the people who wear it.

October has been designated breast cancer month world wide, when thousands of items using the pink ribbon symbol are designed manufactured, produced and sold, in an effort to raise both funds and awareness. During this period fund raising parties, collections, fetes and much more are held for the specific purpose of generating funds for research and to further stimulate awareness.

In the US in 1996 US postage stamp was produced incorporating the pink ribbon symbol, unfortunately this first attempt was not as successful as was hoped. However, later a new design was launched which did not incorporate the pink ribbon, but focused on breast cancer awareness, which did very much better.

In 2006 The Canadian government with the involvement of the Canadian mint engraving director, Cosme Staffioti minted 15,000 coins to commemorate Pink month. On one side the coin was pink and on the other, the head of Queen Elizabeth 2nd. This proved to be extremely popular, so a further 30,000 was produced with similar success. It was the second time in history that colour was used in the minting of coins, destine to be used as legal tender.

The pink campaign has not always had an easy ride and has in the past attracted some criticisms. The main criticism is that the campaign exacerbates the fears of cancer suffers and their relatives, by transforming what for them is a very serious disease, laced with tragedy for all concerned, into a marketing and money-making machinery. Further criticisms have indicated that a great deal of material and memorabilia is produced which serves only to create pollution and has been condemned as ‘pink-washing’.

A San Francisco cancer awareness group have coined a new slogan for their yearly campaign, ‘Think before you pink’ in an effort to encourage campaigners to reflect on the deeper implications of the disease and the devastating impact it has on the lives of the people who are affected and their families.

Current advice is that while breast cancer can affect any age group and viewed as a serious possibility, women over fifty in particular are generally advised to have a mammogram bi-annually, self-examine on a regular basis and any signs of irregularity or abnormality should be taken seriously and investigated without delay. Although men are much less likely to develop the disease they should also examine themselves on a routine basis.